| Source NDC Code |
|
Target HCPCS Code |
70121-1754-01
ALYMSYS 100 MG/4 ML VIAL
|
⇄
|
C9142
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
|
| Detail Information |
| Relationship Start Date |
10/01/2022 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
70121-1754-01
ALYMSYS 100 MG/4 ML VIAL
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
10/01/2022 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
70121-1754-01
ALYMSYS 100 MG/4 ML VIAL
|
⇄
|
Q5126
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg C9142
|
| Detail Information |
| Relationship Start Date |
01/01/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
70121-1754-01
Alymsys
|
⇄
|
Q5126
Inj alymsys 10 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|